Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (801-810 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|July 18, 2022
Age-specific differences in the magnitude of malaria-related anemia during low and high malaria seasons in rural Zambian childrenClement O Acheampong, Maxwell A Barffour, Kerry J Schulze, et al.
Ejhaem|July 18, 2022
Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature reviewTheresa Paul, Anil Yousaf Ellahie, Yazan Salah Almohtasib, et al.
Ejhaem|July 18, 2022
Real-world experience: Introduction of T cell replete haploidentical transplantations in a single centerGwendolyn van Gorkom, Evy Billen, Catharina Van Elssen, et al.
Ejhaem|July 18, 2022
The impact of prior malignancies on the development of second malignancies and survival in follicular lymphoma: A population-based studyManette A W Dinnessen, Otto Visser, Sanne H Tonino, et al.
Ejhaem|July 18, 2022
Fatal renal diseases among patients with hematological malignancies: A population-based studySen Li, Kaixu Yu, Ying Chen, et al.
Ejhaem|July 18, 2022
Favorable prognostic phenotype in myelodysplastic syndrome with der(1;7)(q10;p10)Tomohiro Horio, Megumi Enomoto, Masaya Watarai, et al.
Ejhaem|July 18, 2022
Matching-adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligiblePieter Sonneveld, María-Victoria Mateos, Adrian Alegre, et al.
Ejhaem|July 18, 2022
Predictors of vascular disease in myelodysplastic syndromesMark G Faber, David R Lloyd, Abhay Singh, et al.
Ejhaem|July 18, 2022
Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolismNathaniel R Wilson, Maliha Khan, Travis M Cox, et al.
Ejhaem|July 18, 2022
Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia-related changes with megakaryoblastic differentiationDaniele Avenoso, Pramila Krishnamurthy, Jonathan Salisbury, et al.
Pageof 93

Showing results (801-810 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|July 18, 2022
Age-specific differences in the magnitude of malaria-related anemia during low and high malaria seasons in rural Zambian childrenClement O Acheampong, Maxwell A Barffour, Kerry J Schulze, et al.
Ejhaem|July 18, 2022
Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature reviewTheresa Paul, Anil Yousaf Ellahie, Yazan Salah Almohtasib, et al.
Ejhaem|July 18, 2022
Real-world experience: Introduction of T cell replete haploidentical transplantations in a single centerGwendolyn van Gorkom, Evy Billen, Catharina Van Elssen, et al.
Ejhaem|July 18, 2022
The impact of prior malignancies on the development of second malignancies and survival in follicular lymphoma: A population-based studyManette A W Dinnessen, Otto Visser, Sanne H Tonino, et al.
Ejhaem|July 18, 2022
Fatal renal diseases among patients with hematological malignancies: A population-based studySen Li, Kaixu Yu, Ying Chen, et al.
Ejhaem|July 18, 2022
Favorable prognostic phenotype in myelodysplastic syndrome with der(1;7)(q10;p10)Tomohiro Horio, Megumi Enomoto, Masaya Watarai, et al.
Ejhaem|July 18, 2022
Matching-adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligiblePieter Sonneveld, María-Victoria Mateos, Adrian Alegre, et al.
Ejhaem|July 18, 2022
Predictors of vascular disease in myelodysplastic syndromesMark G Faber, David R Lloyd, Abhay Singh, et al.
Ejhaem|July 18, 2022
Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolismNathaniel R Wilson, Maliha Khan, Travis M Cox, et al.
Ejhaem|July 18, 2022
Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia-related changes with megakaryoblastic differentiationDaniele Avenoso, Pramila Krishnamurthy, Jonathan Salisbury, et al.
Pageof 93